Caffeic acid phenethyl ester [CAPE] - Fight Prostate Ca...

Fight Prostate Cancer

2,910 members1,175 posts

Caffeic acid phenethyl ester [CAPE]

pca2004 profile image
0 Replies

New study [1].

"Caffeic acid phenethyl ester suppresses EGFR/FAK/Akt signaling, migration, and tumor growth of prostate cancer cells"

There have been 2 dozen CAPE papers these last 20 years. Ten of these specifically mention Akt inhibition.

CAPE is found in propolis, which bees use to seal gaps in the hive and protect the colony against infection. (Polis is Greek for "city" or colony.)

I used cheap propolis supplements before discovering that the CAPE content varies & there is often no CAPE at all. I have been using "Manuka Health Propolis Capsules 500Mg, 500 Count" from New Zealand. From the sales pitch: "Scientists have identified very high levels of bioactive compounds including Caffeic Acid Phenethyl Ester (CAPE) in Manuka Health's BIO New Zealand Propolis, for powerful immune support."

From the paper:

"Epidermal growth factor receptor (EGFR) is upregulated in prostate cancer (PCa). However, suppression of EGFR did not improve the patient outcome, possibly due to the activation of PI3K/Akt signaling in PCa. Compounds able to suppress both PI3K/Akt and EGFR signaling may be effective for treating advanced PCa."

"Wound healing assay, transwell migration assay and xenograft mice model were used to determine the effects of CAPE on migration and proliferation of PCa cells."

"CAPE treatment decreased the gene expression of HRAS, RAF1, AKT2, GSK3A, and EGF and the protein expression of phospho-EGFR (Y845, Y1069, Y1148, Y1173), phospho-FAK, Akt, and ERK1/2 in PCa cells.

"CAPE treatment inhibited the EGF-induced migration of PCa cells.

Combined treatment of CAPE with EGFR inhibitor gefitinib showed additive inhibition on migration and proliferation of PCa cells.

"Injection of CAPE (15 mg/kg/3 days) for 14 days suppressed the tumor growth of prostate xenografts in nude mice as well as suppressed the levels of Ki67, phospho-EGFR Y845, MMP-9, phospho-Akt S473, phospho-Akt T308, Ras, and Raf-1 in prostate xenografts."

-Patrick

[1] pubmed.ncbi.nlm.nih.gov/372...

Phytomedicine. 2023 May 3;116:154860. doi: 10.1016/j.phymed.2023.154860.Online ahead of print.

Caffeic acid phenethyl ester suppresses EGFR/FAK/Akt signaling, migration, and tumor growth of prostate cancer cells

Jen-Chih Tseng 1, Bi-Juan Wang 2, Ya-Pei Wang 2, Ying-Yu Kuo 2, Jen-Kun Chen 3, Tzyh-Chyuan Hour 4, Li-Kuo Kuo 5, Po-Jen Hsiao 6, Chien-Chih Yeh 7, Cheng-Li Kao 8, Li-Jane Shih 9, Chih-Pin Chuu 10

PMID: 37201366 DOI: 10.1016/j.phymed.2023.154860

Abstract

Background: Epidermal growth factor receptor (EGFR) is upregulated in prostate cancer (PCa). However, suppression of EGFR did not improve the patient outcome, possibly due to the activation of PI3K/Akt signaling in PCa. Compounds able to suppress both PI3K/Akt and EGFR signaling may be effective for treating advanced PCa.

Purpose: We examined if caffeic acid phenethyl ester (CAPE) simultaneously suppresses the EGFR and Akt signaling, migration and tumor growth in PCa cells.

Methods: Wound healing assay, transwell migration assay and xenograft mice model were used to determine the effects of CAPE on migration and proliferation of PCa cells. Western blot, immunoprecipitation, and immunohistochemistry staining were performed to determine the effects of CAPE on EGFR and Akt signaling.

Results: CAPE treatment decreased the gene expression of HRAS, RAF1, AKT2, GSK3A, and EGF and the protein expression of phospho-EGFR (Y845, Y1069, Y1148, Y1173), phospho-FAK, Akt, and ERK1/2 in PCa cells. CAPE treatment inhibited the EGF-induced migration of PCa cells. Combined treatment of CAPE with EGFR inhibitor gefitinib showed additive inhibition on migration and proliferation of PCa cells. Injection of CAPE (15 mg/kg/3 days) for 14 days suppressed the tumor growth of prostate xenografts in nude mice as well as suppressed the levels of Ki67, phospho-EGFR Y845, MMP-9, phospho-Akt S473, phospho-Akt T308, Ras, and Raf-1 in prostate xenografts.

Conclusions: Our study suggested that CAPE can simultaneously suppress the EGFR and Akt signaling in PCa cells and is a potential therapeutic agent for advanced PCa.

Keywords: Akt; Caffeic acid phenethyl ester; Epidermal growth factor receptor; Fak; Metastasis; Prostate cancer.

Copyright © 2023 The Author(s). Published by Elsevier GmbH.. All rights reserved.

Written by
pca2004 profile image
pca2004
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy

New paper from Spain [1]. "... we will review those strategies and drugs that are able to...
pca2004 profile image

Study Solves Testosterone’s Paradoxical Effects in Prostate Cancer, Duke Health, Published September 04, 2024

This research appears to be a major breakthrough in our understanding of PCa's development and...
cujoe profile image

Docosahexaenoic acid enhances the treatment efficacy for CRPCa by inhibiting autophagy through Atg4B inhibition, 2024 Aug 23

Possible simple dietary intervention to increase autophagy in PCa and boost efficacy of ARSIs....
cujoe profile image

My reaction to Crestor & Nubeqa combo. I need to make some adjustments. This study says simvastatin is best against APC. Your thoughts?

Based on these studies, do you think it's best to use simvastatin as your choice of statins? I'm...

Supraphysiological Androgens [SPA] Promote Tumor Suppressive Activity of the AR Through cMYC Repression and Recruitment of the DREAM Complex

New study [1].  I have struggled to understand how Denmeade’s BAT (Bipolar Androgen Therapy)...
pca2004 profile image